|
USP16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.81350054365248E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62809998816016E-09 |
| Normal-vs-Stage2 |
1.788530E-04 |
| Normal-vs-Stage3 |
2.022600E-04 |
| Normal-vs-Stage4 |
8.29440000000847E-05 |
| Stage1-vs-Stage2 |
7.353000E-01 |
| Stage1-vs-Stage3 |
7.679000E-01 |
| Stage1-vs-Stage4 |
9.290600E-01 |
| Stage2-vs-Stage3 |
5.921400E-01 |
| Stage2-vs-Stage4 |
8.677400E-01 |
| Stage3-vs-Stage4 |
7.733200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.25459667496852E-11 |
| Normal-vs-AfricanAmerican |
1.9423599999957E-05 |
| Normal-vs-Asian |
2.122000E-01 |
| Caucasian-vs-AfricanAmerican |
1.405550E-01 |
| Caucasian-vs-Asian |
3.977000E-01 |
| AfricanAmerican-vs-Asian |
7.443400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.72679656632135E-11 |
| Normal-vs-Female |
9.65419999999773E-05 |
| Male-vs-Female |
1.740220E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.6666000000054E-06 |
| Normal-vs-Extreme_Weight |
2.29079999414239E-09 |
| Normal-vs-Obese |
1.22790000001149E-06 |
| Normal-vs-Extreme_Obese |
3.978000E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.162200E-01 |
| Normal_Weight-vs-Obese |
6.430200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.920800E-01 |
| Extreme_Weight-vs-Obese |
2.194800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.780000E-01 |
| Obese-vs-Extreme_Obese |
3.288000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.983200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.50590000025375E-07 |
| Normal-vs-Age(61-80Yrs) |
4.73660000110954E-11 |
| Normal-vs-Age(81-100Yrs) |
6.813100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.270200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.379590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.547700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.821600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.309700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.689400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.66949964542607E-10 |
| Normal-VS-Type2 PRCC |
7.16759984698001E-10 |
| Normal-VS-KIRP CIMP |
2.301900E-03 |
| Normal-VS-Unclassified PRCC |
2.42149999996055E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.627390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.835400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.663400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.981700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.566200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.182200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.76739767055301E-11 |
| Normal-vs-N1 |
8.981900E-03 |
| Normal-vs-N2 |
2.82959999997612E-06 |
| N0-vs-N1 |
7.702100E-03 |
| N0-vs-N2 |
2.928400E-01 |
| N1-vs-N2 |
3.335700E-02 |
|
|
